Hydrogel Breakthrough Could Extend Effectiveness of Ozempic and Similar Drugs
Scientists have developed an innovative injectable hydrogel that could significantly reduce the frequency of dosing for popular diabetes and weight-loss drugs like Ozempic (semaglutide) and Mounjaro (tirzepatide). The new delivery system, tested in rats, promises to transform treatment regimens by replacing weekly injections with potentially quarterly ones. The hydrogel, created by a team led by…
